|
Balance Sheet Cash Flow Statement 250 Phillips Blvd., Ste. 290 Ewing, NJ 08618 NJ Tel. 609-359-3020 Fax 609-359-3015 |
Type: Public
On the web:
http://www.antarespharma.com
Antares Pharma understands antagonism towards needles. The company develops needle-free systems for administering injectable drugs. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. The Vision system is used primarily for the delivery of insulin and of human growth hormones; it is available over-the-counter and by prescription in the US and is also sold overseas. In addition to its needle-free systems, the company develops other drug delivery platforms, including topical gels, orally-administered disintegrating tablets, and mini-needle injection systems.
Key numbers for fiscal year ending December, 2008:
Sales: $5.7M
One year growth: (28.0%)
Net income: ($12.7)M
Officers:
Chairman: Leonard S. Jacob
President, CEO, and Director: Paul K. Wotton
SVP, CFO, and Secretary: Robert F. (Bob) Apple
Competitors:
Bioject Medical
Elan
Medical House
